lymphoma

(redirected from Hepatosplenic T-cell lymphoma)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

lym·pho·ma

 (lĭm-fō′mə)
n. pl. lym·pho·ma·ta (-mə-tə) or lym·pho·mas
1. Any of various malignant tumors that arise from the lymphocytic cells of the immune system.
2. Any of various cancers characterized by the development of such tumors, especially Hodgkin lymphoma and non-Hodgkin lymphoma.

lym·pho′ma·toid′, lym·pho′ma·tous (-təs) adj.

lymphoma

(lɪmˈfəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) any form of cancer of the lymph nodes. Also called: lymphosarcoma
lymˈphomatous, lymˈphomaˌtoid adj

lym•pho•ma

(lɪmˈfoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor arising from any of the cellular elements of lymph nodes.
[1870–75]
lym•pho′ma•toid`, adj.

lymphoma

a growth of lymphoid tissue that is commonly cancerous and typically enlarges the lymph nodes.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
cancer, malignant neoplastic disease - any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream
Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
Translations
lymfom

lym·pho·ma

n. linfoma, neoplasma del tejido linfático.

lymphoma

n linfoma m; B cell — linfoma de células B; Hodgkin’s — linfoma (de) Hodgkin; mucosa-associated lymphoid tissue (MALT) — linfoma MALT, linfoma de tejido linfoide asociado a mucosas; non-Hodgkin’s — linfoma no Hodgkin; T cell — linfoma de células T
References in periodicals archive ?
9) Hepatosplenic T-cell lymphoma cells have also been shown to produce interferon [gamma], along with some cytolytic activity.
Special Considerations: The FDA and Centocor added a black box warning about hepatosplenic T-cell lymphoma.
Since the report of the first case in 1990 by Falco et al, approximately 150 cases of hepatosplenic T-cell lymphoma (HSTCL) have been reported, accounting for less than 5% of all peripheral T/NK (natural killer)-cell lymphomas.
The Remicade prescribing information also includes information about the risk of hepatosplenic T-cell lymphoma in children and young adults treated with the biologic and other immunosuppressive drugs for Crohn's disease, a warning that was added to the label in 2006.